Cargando…

肺癌切除术后肺内孤立性转移复发灶的射频消融治疗

BACKGROUND AND OBJECTIVE: Primary lung cancer is one of the most common malignancies worldwide. Surgical resection remains the first choice for the treatment of early stage non-small cell lung cancer (NSCLC). Relapse after surgery sharply reduces the patient's life expectancy. This relapse is r...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000097/
https://www.ncbi.nlm.nih.gov/pubmed/24949685
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.06.04
_version_ 1783331617022935040
collection PubMed
description BACKGROUND AND OBJECTIVE: Primary lung cancer is one of the most common malignancies worldwide. Surgical resection remains the first choice for the treatment of early stage non-small cell lung cancer (NSCLC). Relapse after surgery sharply reduces the patient's life expectancy. This relapse is referred to as isolated postsurgical local recurrences or metastases (IPSLROM), which can be treated via local therapy to achieve long-term survival or cure. In recent years, radiofrequency ablation (RFA) has been increasingly used as a non-surgical treatment option for patients with primary and metastatic lung tumors. This study aims to evaluate the efficacy of RFA among patients with IPSLROM of NSCLC. METHODS: A total of 20 patients underwent computerd tomograghy (CT)-guided RFA for lung neoplasm with IPSLROM of NSCLC (with unresectable disease because of poor lung reserve or multifocality) in our hospital between December 2008 and November 2013. These patients comprised 15 males and 5 females with a mean age of 69.2 years (range: 45-85). All patients exhibited pathological evidence of neoplastic lesion (14 tumors were adenocarcinoma, and six were squamous cell carcinoma). The mean size of the lesions was 3.9 cm (range: 2.0 cm to 8.0 cm). Treatment complications, progression-free survival (PFS), and survival parameters were retrospectively analyzed. RESULTS: RFA was well tolerated by all patients with an average time of 34.3 min (range: 15 min to 60 min). Intraprocedural complications included eight cases of chest pain (40%). No procedure-related deaths occurred in all of the 20 ablation procedures. The median PFS was 25 months in all of the patients who received RFA. The median overall survival for the entire group of patients was 27.0 months. No differences were observed in the overall survival between patients with IPSLROM. The overall survival rates at 1 and 2 years after RFA were 92.9% and 57.0%, respectively. CONCLUSION: RFA is a safe and effective procedure in unresectable lung tumors with IPSLROM of NSCLC.
format Online
Article
Text
id pubmed-6000097
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-60000972018-07-06 肺癌切除术后肺内孤立性转移复发灶的射频消融治疗 Zhongguo Fei Ai Za Zhi 临床经验 BACKGROUND AND OBJECTIVE: Primary lung cancer is one of the most common malignancies worldwide. Surgical resection remains the first choice for the treatment of early stage non-small cell lung cancer (NSCLC). Relapse after surgery sharply reduces the patient's life expectancy. This relapse is referred to as isolated postsurgical local recurrences or metastases (IPSLROM), which can be treated via local therapy to achieve long-term survival or cure. In recent years, radiofrequency ablation (RFA) has been increasingly used as a non-surgical treatment option for patients with primary and metastatic lung tumors. This study aims to evaluate the efficacy of RFA among patients with IPSLROM of NSCLC. METHODS: A total of 20 patients underwent computerd tomograghy (CT)-guided RFA for lung neoplasm with IPSLROM of NSCLC (with unresectable disease because of poor lung reserve or multifocality) in our hospital between December 2008 and November 2013. These patients comprised 15 males and 5 females with a mean age of 69.2 years (range: 45-85). All patients exhibited pathological evidence of neoplastic lesion (14 tumors were adenocarcinoma, and six were squamous cell carcinoma). The mean size of the lesions was 3.9 cm (range: 2.0 cm to 8.0 cm). Treatment complications, progression-free survival (PFS), and survival parameters were retrospectively analyzed. RESULTS: RFA was well tolerated by all patients with an average time of 34.3 min (range: 15 min to 60 min). Intraprocedural complications included eight cases of chest pain (40%). No procedure-related deaths occurred in all of the 20 ablation procedures. The median PFS was 25 months in all of the patients who received RFA. The median overall survival for the entire group of patients was 27.0 months. No differences were observed in the overall survival between patients with IPSLROM. The overall survival rates at 1 and 2 years after RFA were 92.9% and 57.0%, respectively. CONCLUSION: RFA is a safe and effective procedure in unresectable lung tumors with IPSLROM of NSCLC. 中国肺癌杂志编辑部 2014-06-20 /pmc/articles/PMC6000097/ /pubmed/24949685 http://dx.doi.org/10.3779/j.issn.1009-3419.2014.06.04 Text en 版权所有©《中国肺癌杂志》编辑部2014 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 临床经验
肺癌切除术后肺内孤立性转移复发灶的射频消融治疗
title 肺癌切除术后肺内孤立性转移复发灶的射频消融治疗
title_full 肺癌切除术后肺内孤立性转移复发灶的射频消融治疗
title_fullStr 肺癌切除术后肺内孤立性转移复发灶的射频消融治疗
title_full_unstemmed 肺癌切除术后肺内孤立性转移复发灶的射频消融治疗
title_short 肺癌切除术后肺内孤立性转移复发灶的射频消融治疗
title_sort 肺癌切除术后肺内孤立性转移复发灶的射频消融治疗
topic 临床经验
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6000097/
https://www.ncbi.nlm.nih.gov/pubmed/24949685
http://dx.doi.org/10.3779/j.issn.1009-3419.2014.06.04
work_keys_str_mv AT fèiáiqièchúshùhòufèinèigūlìxìngzhuǎnyífùfāzàodeshèpínxiāoróngzhìliáo
AT fèiáiqièchúshùhòufèinèigūlìxìngzhuǎnyífùfāzàodeshèpínxiāoróngzhìliáo
AT fèiáiqièchúshùhòufèinèigūlìxìngzhuǎnyífùfāzàodeshèpínxiāoróngzhìliáo
AT fèiáiqièchúshùhòufèinèigūlìxìngzhuǎnyífùfāzàodeshèpínxiāoróngzhìliáo
AT fèiáiqièchúshùhòufèinèigūlìxìngzhuǎnyífùfāzàodeshèpínxiāoróngzhìliáo
AT fèiáiqièchúshùhòufèinèigūlìxìngzhuǎnyífùfāzàodeshèpínxiāoróngzhìliáo